Related Experiment Video
Updated: Mar 25, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Absolute and Functional Iron Deficiency Is a Common Finding in Patients With Heart Failure and After Heart
P Przybylowski1, G Wasilewski1, K Golabek2
1Department of Cardiac Surgery and Transplantology, Collegium Medicum, Jagiellonian University, Cracow, Poland.
Anemia is common in heart failure and transplant patients due to absolute and functional iron deficiency. Screening for inflammation is crucial for managing these conditions.
Area of Science:
- Cardiology
- Hematology
- Transplantation Medicine
Background:
- Anemia is prevalent in heart failure and heart transplant recipients.
- Both absolute and functional iron deficiency contribute to anemia in these patient groups.
- Functional iron deficiency involves adequate iron stores but insufficient mobilization.
Purpose of the Study:
- To determine the prevalence of absolute and functional iron deficiency.
- To explore the relationship between iron deficiency and iron status/inflammation parameters.
- To compare these findings in heart failure patients and heart transplant recipients.
Main Methods:
- Assessed iron status, complete blood count, and creatinine.
- Measured C-reactive protein, hepcidin, and hemojuvelin using commercial kits.
- Analyzed data from 269 heart failure patients and 130 heart transplant recipients.
Main Results:
- Absolute iron deficiency: 15% (HF) vs 30% (HTR).
- Functional iron deficiency: 18% (HF) vs 17% (HTR).
- Anemia prevalence higher in HTR (40% vs 22%), associated with worse kidney function.
Conclusions:
- Absolute and functional iron deficiency affect a significant number of patients.
- Higher C-reactive protein and hepcidin levels correlate with functional iron deficiency.
- Patients require screening for reversible inflammation causes.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy

